| Russell Harms Dpm Pc | |
|
1214 E National Ave, Suite 130, Brazil, IN 47834-2700 | |
| (812) 448-9290 | |
| (812) 448-9296 |
| Full Name | Russell Harms Dpm Pc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 1214 E National Ave, Brazil, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114162435 | NPI | - | NPPES |
| 200938770 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 41000207 (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Russell Harms Dpm Pc 1214 E National Ave, Suite 130, Brazil, IN 47834-2700 Ph: (812) 448-9290 | Russell Harms Dpm Pc 1214 E National Ave, Suite 130, Brazil, IN 47834-2700 Ph: (812) 448-9290 |
News Archive
A physically and mentally active lifestyle confers resilience to frontotemporal dementia (FTD), even in people whose genetic profile makes the eventual development of the disease virtually inevitable, according to new research by scientists at the UC San Francisco Memory and Aging Center.
More and more data from preclinical and clinical studies strengthen the hypothesis that immune system-mediated actions contribute to and drive pathogenesis in Alzheimer's disease. The team of Roosmarijn Vandenbroucke in the Claude Libert Group (VIB/UGent) combined their knowledge and expertise related to inflammation with the expertise in Alzheimer's disease present in the Bart De Strooper Group (VIB/KU Leuven).
Keryx Biopharmaceuticals, Inc. announced today the initiation of a Phase 3 registration clinical trial for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of patients with refractory advanced colorectal cancer.
23andMe, Inc., the leading personal genetics company, today announced the publication of the first ever genome-wide association study of motion sickness.
› Verified 8 days ago
Dr. Miranda Anne Goodale, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 955 W Craig Ave, Brazil, IN 47834 Phone: 812-448-9290 Fax: 812-448-9296 | |
Dr. Russell C Harms, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1214 E National Ave, Suit 130, Brazil, IN 47834 Phone: 812-448-9290 Fax: 812-448-9296 | |
Clay County Podiatry, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 955 W Craig Ave, Brazil, IN 47834 Phone: 812-448-9290 Fax: 812-448-9296 |